These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9872619)

  • 21. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.
    Fu W; Song Z; Zhou L; Xue Y; Ding Y; Suo B; Tian X; Wang L
    Dig Dis Sci; 2017 Jun; 62(6):1580-1589. PubMed ID: 28391418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
    Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
    Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi-ethnic European city.
    den Hollander WJ; Holster IL; den Hoed CM; van Deurzen F; van Vuuren AJ; Jaddoe VW; Hofman A; Perez Perez GI; Blaser MJ; Moll HA; Kuipers EJ
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1705-11. PubMed ID: 23808840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eradication Rate of
    Liu RP; Romero R; Sarosiek J; Dodoo C; Dwivedi AK; Zuckerman MJ
    South Med J; 2018 Jan; 111(1):51-55. PubMed ID: 29298370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori infection in Turkish children: comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication.
    Ozçay F; Koçak N; Temizel IN; Demir H; Ozen H; Yüce A; Gürakan F
    Helicobacter; 2004 Jun; 9(3):242-8. PubMed ID: 15165260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it.
    Gisbert JP; Pajares JM; García-Valriberas R; Abraira V; Boixeda D; García-Grávalos R; Martín-de-Argila C; García-Plaza A
    Scand J Gastroenterol; 1998 Nov; 33(11):1144-51. PubMed ID: 9867091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
    Aktaş B; Başyiğit S; Yüksel O; Akkan T; Atbaşı ST; Uzman M; Yılmaz B; Şimşek G; Nazlıgül Y
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):769-75. PubMed ID: 25919773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days.
    Knigge K; Kelly C; Peterson WL; Fennerty MB
    Aliment Pharmacol Ther; 1999 Mar; 13(3):323-6. PubMed ID: 10102965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride.
    Williams MP; Hamilton MR; Sercombe JC; Pounder RE
    Aliment Pharmacol Ther; 1997 Aug; 11(4):705-10. PubMed ID: 9305479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group.
    Moayyedi P; Feltbower R; Crocombe W; Mason S; Atha P; Brown J; Dowell AC; Richards ID; Axon AT
    Aliment Pharmacol Ther; 2000 Jun; 14(6):719-28. PubMed ID: 10848655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.
    Savarino V; Mansi C; Mele MR; Bisso G; Mela GS; Saggioro A; Caroli M; Vigneri S; Termini R; Olivieri A; Tosatto R; Celle G
    Aliment Pharmacol Ther; 1997 Aug; 11(4):699-703. PubMed ID: 9305478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A triple therapy regimen after failed Helicobacter pylori treatments.
    Zullo A; Hassan C; Campo SM; Lorenzetti R; Febbraro I; De Matthaeis M; Porto D; Morini S
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1193-7. PubMed ID: 11472322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal Trends in Helicobacter pylori Eradication Success in a Test-and-Treat Population.
    Boltin D; Schmilovitz-Weiss H; Gingold-Belfer R; Leibovitzh H; Snir Y; Perets TT; Dickman R; Levi Z; Niv Y
    Digestion; 2018; 98(3):169-174. PubMed ID: 29870988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
    Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study.
    Alizadeh-Naeeni M; Saberi-Firoozi M; Pourkhajeh A; Taheri H; Malekzadeh R; Derakhshan MH; Massarrat S;
    Digestion; 2002; 66(2):92-8. PubMed ID: 12428068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection.
    Savarino V; Zentilin P; Bisso G; Pivari M; Bilardi C; Biagini R; Mele MR; Mansi C; Termini R; Vigneri S; Celle G
    Aliment Pharmacol Ther; 1999 Jan; 13(1):43-7. PubMed ID: 9892878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.